Quest Diagnostics Incorporated (DGX) – Impact of decline in covid-19 testing

DGX entered into a collaboration with IRIS to provide diabetic retinal imaging services through the designated Quest Diagnostics patient service centers across US. Given the market prospects, DGX’s new collaboration to enhance access to screening for diabetic retinopathy seems well-timed.

Highlights

Valuation

– Enterprise Value
– CrispIdea Forecast
– Economic Value Added Analysis
– Discounted Cash Flow Analysis.
– P/E Analysis
– Peer Valuation
– CrispIdea Forecast Relative to Consensus
– Consensus History and Surprise
– Consensus Momentum

Actual & Historical Performance

– Income Statement
– Balance Sheet
– Cash Flow
– 10 Year Historical Performance
– Ratio Analysis
– Du Pont Analysis
– ROIC & ROCE Analysis
– Segment Performance
– M&A Deals

Peer Performance

– Summary
– Profitability
– Growth
– Price Performance

Ownership

Stock Price Performance

Crispidea Coverage

No of Pages : 33